[1]
“Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study”, Swiss Med Wkly, vol. 150, no. 4950, p. w20354, Dec. 2020, doi: 10.4414/smw.2020.20354.